SULFAIR FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Sulfair Forte patents expire, and when can generic versions of Sulfair Forte launch?
Sulfair Forte is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in SULFAIR FORTE is sulfacetamide sodium. There are three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfair Forte
A generic version of SULFAIR FORTE was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
Summary for SULFAIR FORTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 66 |
Patent Applications: | 1,057 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULFAIR FORTE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SULFAIR FORTE
US Patents and Regulatory Information for SULFAIR FORTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | SULFAIR FORTE | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 088385-001 | Oct 13, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |